Please wait while the formulary information is being retrieved.
CISPLATIN (CISPLATIN)
- Invasive bladder malignancy
- Malignant neoplasm of the ovary
- Ovarian germ cell tumor carcinoma
- Small cell lung carcinoma
- Testicular germ cell tumor
1 mg/mL intravenous solution
- Dosage information is not available
1 mg/mL intravenous solution
- Dosage information is not available
50 mg intravenous powder for solution
- Dosage information is not available
Progressive diffuse large b-cell lymphoma
- Infuse 100 mg/m2 by intravenous route once
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- Apatate
- Apetigen Plus
- B Complex
- B Complex 100
- B complex-C-E-FA-Zn-lysine
- B complex-C-min-Fe-FA
- B cplx-C-St.Johnwrt-K.&S.ginsg
- B&C-iron fum-FA-vit E-AA#16
- B-100 Complex
- B-natal
- B1-B2-B3-B5-B6-iron-met-choln
- B100 Balanced
- B3-azelaic-zinc-B6-copper-FA
- Balanced B-100 Complex
- BCG vaccine, live (PF)
- Beelith
- Ca cmb no.1-D3-B-6-FA-B12-aloe
- Ca cmb no.1-vit D3-B6-FA-B12
- Calcium Citrate + D With Mag
- Calcium Citrate Plus
- calcium-mag-B6-B12-D3-FA-boron
- calcium-mag-vit B6-D3-minerals
- calcium-vit B6-E-FA-herbal
- Cardiotek-rx (bioperine)
- Cerefolin
- cidofovir
- Citranatal B-calm (fe Gluc)
- Corvita 150
- Corvite 150
- Dialyvite
- Dialyvite 3000
- Dialyvite 800
- Dialyvite 800 With Iron
- Dialyvite 800-ultra D
- Diclegis
- doxylamine-pyridoxine
- FA-arginine-B12-B6-blackpepper
- FA-vit B comp&C-selenium-zinc
- Fabb
- Farbee With C
- Fatigue Relief Complex
- Ferrocite Plus
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- Folbecal
- Folbee
- Folbee Ar
- Folbee Plus
- Folbic
- Folgard Os
- Folgard Rx
- folic acid-vit B6-vit B12
- Folic Acid-vit B6-vit B12 (ca)
- Folinatal Plus B
- Folplex 2.2
- Foltabs 800
- Geritol Tonic With Ferrex 18
- glucosamine &chondroit-mv-min3
- Glucoten
- Glycotrol
- Heartburn & Acid Reflux
- Heartburn & Acid Reflux W/aloe
- Hematinic Plus Vit/minerals
- Homocysteine Formula
- Iro-plex (iron Carbonyl)
- Iro-plex (iron Polysaccharide)
- iron fum-liver ext-B complex-C
- iron fum-vit C-B complex-FA
- iron, carb-FA-C-B6-B12-zinc
- iron-C-B12-B6-E-FA-IF-senna
- iron-FA-B cmplx-vit C-DSS
- iron-lysine-vit E-B cplx-zinc
- iron-vit B cplx-C-min-liver ex
- iron-vitC-B12-B6-E-FA-IF-senna
- Kelp-lecithin-b6
- Kelp-lecithin-b6-vinegar
- L-methyl-mc
- Lecithin-kelp-b6
- Lecithin-kelp-b6 (100-8.3)
- Lecithin-kelp-b6 (400-20)
- levomefolate-B2-B6-B12
- Liver With Iron
- Lysiplex Plus
- M-m-r Ii (pf)
- magnesium oxide-pyridoxine HCl
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- Melatonin (with B6)
- melatonin-pyridoxine (vit B6)
- melatonin-pyridoxine HCl (B6)
- Mens Potent Formula
- Metafolbic
- Minus Weight Plus Energy
- Mynephrocaps
- natalizumab
- Natural B-100 Complex
- Nephro-vite
- Nephrocaps
- Nephron Fa
- Neuro Vite
- Nicazel
- nut sup, glucose intolerant #1
- nut.tx, metab.dis, mv & min #4
- om 3-dha-epa-B12-FA-B6-phytost
- om-3-dha-epa-D3-B12-FA-B-6-phy
- pedi multivit #37 w-fluoride
- pedi multivit #37-fluor & iron
- pediatric multivit no.64-D3-K
- pnv w-o iron-FA-calcium-B6-B12
- pnv with calcium#63-iron-FA-B6
- PNV-FA-B6-calcium phos-ginger
- Poly-vi-flor
- Poly-vi-flor With Iron
- Prenaissance Next
- prenatal #48-iron cb&glu-FA-B6
- Proquad (pf)
- Prorenal Vital
- pyridoxine
- pyridoxine-kelp-lect-vinegar
- Rena-vite
- Renal Caps
- Reno Caps
- Resource Diabetishield
- Rotateq Vaccine
- rotavirus vaccine live, penta
- Siderol
- Stress Formula Energy
- Super B/c
- Superplex-t
- Support-500
- Taron-bc
- Theralith Xr
- Tl G-fol Os
- Tl Gard Rx
- Total B/c
- Triphrocaps
- typhoid vaccine
- Tysabri
- Ultra Inflamx Plus 360
- varicella virus vacc live (PF)
- Varisan Vitality
- Varivax (pf)
- Vinacal B
- Virt-vite
- Virt-vite Forte
- Vistide
- Vit 3
- vit B complex 100 combo no.2
- vit B&C-iron fum-FA-D3-zinc ox
- vit B1-B2-B3-B5-B6
- vit B12-FA-pyridoxine-AA no.15
- vit B2-niac-B-6-B12-D-panth
- vit B6-mag cit & ox-potass cit
- vit C-B6-B5-magnesium-hrb #173
- vit E-rut-hesp-bio-B&C-hb 111
- Vita-respa
- Vitabee/c
- Vivotif Berna Vaccine
- Vp-ggr-b6
- Vp-zel
- Xydra Ef
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zingiber
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- clozapine
- Clozaril
- deferiprone
- Fazaclo
- Ferriprox
- Versacloz
Severe
Moderate
- Abraxane
- adefovir
- Atripla
- Cerebyx
- Complera
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- efavirenz-emtricitabin-tenofov
- elvitegr-cobicist-emtric-tenof
- emtricitab-rilpivirine-tenofov
- emtricitabine-tenofovir
- ethotoin
- fosphenytoin
- gentamicin
- gentamicin in NaCl (iso-osm)
- gentamicin sulfate (ped) (PF)
- gentamicin sulfate (PF)
- Hepsera
- Onxol
- paclitaxel
- paclitaxel-protein bound
- Peganone
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- Stribild
- tenofovir disoproxil fumarate
- Truvada
- Viread
- Kidney disease with reduction in GFR
- Lactating mother
Contraindicated
- Acute leukemia
- Acute myocardial infarction
- Anemia
- Cerebral arteritis
- Cerebrovascular accident
- Deep venous thrombosis
- Hearing loss
- Hemolytic uremic syndrome
- Hyperuricemia
- Hypocalcemia
- Hypokalemia
- Hypomagnesemia
- Hyponatremia
- Kidney disease with likely reduction in GFR
- Leukopenia
- Optic neuritis
- Ototoxicity
- Peripheral neuropathy
- Posterior reversible encephalopathy syndrome
- Pregnancy
- Pulmonary thromboembolism
- Severe infection
- Thrombocytopenic disorder
- Thrombosis of aorta
- Thrombotic thrombocytopenic purpura
- TPMT poor metabolizer
Severe
Moderate
- Raynaud's phenomenon
- Vomiting
CISPLATIN (CISPLATIN)
- Invasive bladder malignancy
- Malignant neoplasm of the ovary
- Ovarian germ cell tumor carcinoma
- Small cell lung carcinoma
- Testicular germ cell tumor
- Anemia
- Bone marrow depression
- Hemolytic anemia
- Hyperuricemia
- Hypomagnesemia
- Leukopenia
- Nausea
- Nephrotoxicity
- Ototoxicity
- Thrombocytopenic disorder
- Uric acid nephropathy
- Vomiting
- Peripheral neuropathy
More Frequent
Severe
Less Severe
- Anaphylaxis
- Bronchospastic pulmonary disease
- CNS toxicity
- Injection site sequelae
- Urticaria
- Alopecia
- Anorexia
- General weakness
- Malaise
- Paresthesia
- Skin rash
- Stomatitis
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute myeloid leukemia
- Acute myocardial infarction
- Acute renal failure
- Azoospermia
- Cellulitis
- Cerebral arteritis
- Cerebrovascular accident
- Chemotherapy-induced hyperuricemia
- Color blindness
- Cortical blindness
- Facial edema
- Gastrointestinal perforation
- Hemolytic uremic syndrome
- Hepatic veno-occlusive disease
- Hyperbilirubinemia
- Hypersensitivity drug reaction
- Hypocalcemia
- Hypokalemia
- Hyponatremia
- Hypophosphatemia
- Infection
- Infertility
- Interstitial pneumonitis
- Leukoencephalopathy
- Oligospermia
- Optic neuritis
- Pancreatitis
- Papilledema
- Pericardial effusion
- Pigmentary retinopathy
- Posterior reversible encephalopathy syndrome
- Progressive multifocal leukoencephalopathy
- Pulmonary thromboembolism
- Raynaud's phenomenon
- Secondary ovarian failure
- Seizure disorder
- SIADH syndrome
- Sudden visual loss
- Tachycardia
- Tetany
- Thromboembolic disorder
- Thrombosis of aorta
- Thrombotic thrombocytopenic purpura
- Ventricular arrhythmias
Less Severe
- Blurred vision
- Cramps
- Dehydration
- Diarrhea
- Dysgeusia
- Fever
- Hiccups
- Hypotension
- Wheezing
Contraindicated
None
Severe Precaution
Cisplatin
Severe ototoxicity and vestibular toxicity observed. Risk may increase with thiopurine S-methyltransferase gene variant. Audiometry recommended prior to, during and after treatment. No safety and efficacy established.
- 1 Day – 13 Years
- Severe ototoxicity and vestibular toxicity observed. Risk may increase with thiopurine S-methyltransferase gene variant. Audiometry recommended prior to, during and after treatment. No safety and efficacy established.
Management or Monitoring Precaution
None
Cisplatin
- Severity Level:
D
- Additional Notes: Available human data suggest increased risk of developmental toxicity
Contraindicated
Cisplatin
Manufacturer does not recommend
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Excreted | Not known; no or inclusive data | Manufacturer does not recommend |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Cisplatin
General-Increased risk for adverse effects (e.g. renal, neuro, myelosuppression, infection). Renal-Increased susceptibility to nephrotoxicity; may consider reduced dose. Contraindicated with pre-existing renal impairment. Neuro/Psych-Increased risk of peripheral neuropathy in elderly. Endocrine-May exacerbate or cause hyponatremia; monitor sodium level closely when starting or changing dosages. Rare risk of SIADH.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | N | Y | N | Y |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- Cisplatin may cause severe kidney problems, nerve problems, and severe nausea and vomiting. Nerve problems may occur during treatment or weeks after stopping treatment. Your risk of these problems increases with higher doses or longer treatment with cisplatin.<br /><br />Tell your doctor right way if you develop any of the following symptoms: change in the amount of urine, numbness/tingling of arms/legs, loss of reflexes, loss of balance, trouble walking, nausea, or vomiting. This medication decreases bone marrow function, an effect that may lead to a low number of blood cells such as red cells, white cells, and platelets. This effect can cause anemia, decrease your body's ability to fight an infection, or cause easy bruising/bleeding. Tell your doctor right away if you develop any of the following symptoms: unusual tiredness, pale skin, easy bruising/bleeding, or signs of infection (such as sore throat that doesn't go away, fever, chills).
| Invasive bladder malignancy | |
| C67 | Malignant neoplasm of bladder |
| C67.0 | Malignant neoplasm of trigone of bladder |
| C67.1 | Malignant neoplasm of dome of bladder |
| C67.2 | Malignant neoplasm of lateral wall of bladder |
| C67.3 | Malignant neoplasm of anterior wall of bladder |
| C67.4 | Malignant neoplasm of posterior wall of bladder |
| C67.5 | Malignant neoplasm of bladder neck |
| C67.6 | Malignant neoplasm of ureteric orifice |
| C67.7 | Malignant neoplasm of urachus |
| C67.8 | Malignant neoplasm of overlapping sites of bladder |
| C67.9 | Malignant neoplasm of bladder, unspecified |
| Malignant neoplasm of the ovary | |
| C56 | Malignant neoplasm of ovary |
| C56.1 | Malignant neoplasm of right ovary |
| C56.2 | Malignant neoplasm of left ovary |
| C56.9 | Malignant neoplasm of unspecified ovary |
| Ovarian germ cell tumor carcinoma | |
| C56 | Malignant neoplasm of ovary |
| C56.1 | Malignant neoplasm of right ovary |
| C56.2 | Malignant neoplasm of left ovary |
| C56.9 | Malignant neoplasm of unspecified ovary |
| Small cell lung carcinoma | |
| C34 | Malignant neoplasm of bronchus and lung |
| C34.0 | Malignant neoplasm of main bronchus |
| C34.00 | Malignant neoplasm of unspecified main bronchus |
| C34.01 | Malignant neoplasm of right main bronchus |
| C34.02 | Malignant neoplasm of left main bronchus |
| C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
| C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
| C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
| C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
| C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
| C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
| C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
| C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
| Testicular germ cell tumor | |
| C62 | Malignant neoplasm of testis |
| C62.0 | Malignant neoplasm of undescended testis |
| C62.00 | Malignant neoplasm of unspecified undescended testis |
| C62.01 | Malignant neoplasm of undescended right testis |
| C62.02 | Malignant neoplasm of undescended left testis |
| C62.1 | Malignant neoplasm of descended testis |
| C62.10 | Malignant neoplasm of unspecified descended testis |
| C62.11 | Malignant neoplasm of descended right testis |
| C62.12 | Malignant neoplasm of descended left testis |
| C62.9 | Malignant neoplasm of testis, unspecified whether descended or undescended |
| C62.90 | Malignant neoplasm of unspecified testis, unspecified whether descended or undescended |
| C62.91 | Malignant neoplasm of right testis, unspecified whether descended or undescended |
| C62.92 | Malignant neoplasm of left testis, unspecified whether descended or undescended |
| 0-9 | A-Z |
|---|---|
| C34 | Malignant neoplasm of bronchus and lung |
| C34.0 | Malignant neoplasm of main bronchus |
| C34.00 | Malignant neoplasm of unspecified main bronchus |
| C34.01 | Malignant neoplasm of right main bronchus |
| C34.02 | Malignant neoplasm of left main bronchus |
| C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
| C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
| C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
| C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
| C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
| C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
| C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
| C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
| C56 | Malignant neoplasm of ovary |
| C56 | Malignant neoplasm of ovary |
| C56.1 | Malignant neoplasm of right ovary |
| C56.1 | Malignant neoplasm of right ovary |
| C56.2 | Malignant neoplasm of left ovary |
| C56.2 | Malignant neoplasm of left ovary |
| C56.9 | Malignant neoplasm of unspecified ovary |
| C56.9 | Malignant neoplasm of unspecified ovary |
| C62 | Malignant neoplasm of testis |
| C62.0 | Malignant neoplasm of undescended testis |
| C62.00 | Malignant neoplasm of unspecified undescended testis |
| C62.01 | Malignant neoplasm of undescended right testis |
| C62.02 | Malignant neoplasm of undescended left testis |
| C62.1 | Malignant neoplasm of descended testis |
| C62.10 | Malignant neoplasm of unspecified descended testis |
| C62.11 | Malignant neoplasm of descended right testis |
| C62.12 | Malignant neoplasm of descended left testis |
| C62.9 | Malignant neoplasm of testis, unspecified whether descended or undescended |
| C62.90 | Malignant neoplasm of unspecified testis, unspecified whether descended or undescended |
| C62.91 | Malignant neoplasm of right testis, unspecified whether descended or undescended |
| C62.92 | Malignant neoplasm of left testis, unspecified whether descended or undescended |
| C67 | Malignant neoplasm of bladder |
| C67.0 | Malignant neoplasm of trigone of bladder |
| C67.1 | Malignant neoplasm of dome of bladder |
| C67.2 | Malignant neoplasm of lateral wall of bladder |
| C67.3 | Malignant neoplasm of anterior wall of bladder |
| C67.4 | Malignant neoplasm of posterior wall of bladder |
| C67.5 | Malignant neoplasm of bladder neck |
| C67.6 | Malignant neoplasm of ureteric orifice |
| C67.7 | Malignant neoplasm of urachus |
| C67.8 | Malignant neoplasm of overlapping sites of bladder |
| C67.9 | Malignant neoplasm of bladder, unspecified |
Formulary Reference Tool